Market report
Dermatological drug tenders in Czechia — market report, February 2026
Dermatological drug tenders in Czechia in February 2026: 6,960 tenders published (-13% month on month, -25% year on year), estimated at €434,751 in total, and 6,903 contracts awarded (-14% month on month, -26% year on year), worth €20,170,723 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,025), Krajská zdravotní, a.s. (809) and Fakultní nemocnice Bulovka (656); most contracts won: ViaPharma s.r.o. (176), ROCHE s.r.o. (155) and Takeda Pharmaceuticals Czech Republic s.r.o. (113). On average 1.8 bids per contract; 52% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 6,960
- Contracts awarded
- 6,903
- Contract value awarded
- €20,170,723
- Bids per contract
- 1.8
The highlighted bar is February 2026. Hover a bar for its figure; the table below has every value.
| Figure | February 2026 | January 2026 | Change | February 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 6,960 | 7,997 | -13% | 9,302 | -25% |
| Estimated value | €434,751 | €214,027 | +103% | €122,469 | +255% |
| Buyers | 30 | 29 | +3% | 30 | 0% |
| Contracts awarded | 6,903 | 8,003 | -14% | 9,292 | -26% |
| Contract value (awarded) | €20,170,723 | €199,923 | +9,989% | — | — |
| Winners | 295 | 308 | -4% | 267 | +10% |
| Bids per contract | 1.8 | 1.9 | — | 1.8 | — |
| Single-bid contracts | 52% | 25% | — | 40% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 176 |
| 2 | ROCHE s.r.o. | 155 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 113 |
| 4 | Janssen-Cilag s.r.o. | 112 |
| 5 | AbbVie s.r.o. | 110 |
| 6 | Amgen s.r.o. | 94 |
| 7 | Avenier a.s. | 84 |
| 8 | BAYER s.r.o. | 82 |
| 9 | ELI LILLY ČR, s.r.o. | 62 |
| 10 | Gilead Sciences s.r.o. | 59 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in February 2026?
- 6,960 (by 30 buyers); for comparison, January 2026: 7,997, February 2025: 9,302.
- Who won the most dermatological drug tenders in Czechia in February 2026?
- By number of contracts: ViaPharma s.r.o. (176), ROCHE s.r.o. (155), Takeda Pharmaceuticals Czech Republic s.r.o. (113), Janssen-Cilag s.r.o. (112) and AbbVie s.r.o. (110); 295 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in February 2026?
- Krajská nemocnice T. Bati, a. s. (2,025), Krajská zdravotní, a.s. (809), Fakultní nemocnice Bulovka (656), Fakultní nemocnice Brno (413) and Nemocnice České Budějovice, a.s. (320).
- How competitive were dermatological drug tenders in Czechia in February 2026?
- On average 1.8 bids per contract (25 contracts with a known number of bids); 52% of contracts had a single bid.
- What were the contracts worth in February 2026?
- €20,170,723 (awarded value, 6,903 contracts); median about €410,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.